JE-CV Vaccine + Varicella Vaccine
Phase 3Completed 2 views this week 0 watching⚡ Active
Interest: 40/100
40
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 24
Phase 35
ApprovedIndication / Disease
Japanese Encephalitis
Conditions
Japanese Encephalitis, Varicella
Trial Timeline
Aug 25, 2010 → Oct 12, 2015
NCT ID
NCT01190228About JE-CV Vaccine + Varicella Vaccine
JE-CV Vaccine + Varicella Vaccine is a phase 3 stage product being developed by Sanofi for Japanese Encephalitis. The current trial status is completed. This product is registered under clinical trial identifier NCT01190228. Target conditions include Japanese Encephalitis, Varicella.
What happened to similar drugs?
3 of 20 similar drugs in Japanese Encephalitis were approved
Approved (3) Terminated (0) Active (17)
Hype Score Breakdown
Clinical
17
Activity
8
Company
15
Novelty
0
Community
0
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT01190228 | Phase 3 | Completed |
Competing Products
20 competing products in Japanese Encephalitis